Expression of PRPSAP1 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

PRPSAP1 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 35.91

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

33.7

Number of samples

141

Samples

Sample	Description	TPM
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	151.5
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	60.3
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	53.7
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	51.4
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	51.1
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	49.9
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	49.3
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	48.5
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	47.1
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	46.4
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	46.3
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	44.9
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	44.6
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	44.0
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	43.6
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	43.0
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	42.6
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	42.4
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	42.4
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	42.0
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	41.9
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	41.6
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	41.0
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	40.5
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	39.8
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	39.6
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	39.1
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	39.1
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	38.3
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	38.1
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	38.0
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	38.0
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	37.8
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	37.6
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	37.6
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	37.5
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	37.4
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	37.4
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	36.9
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	36.9
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	36.8
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	36.8
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	36.7
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	36.3
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	36.1
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	36.0
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	35.9
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	35.9
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	35.8
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	35.7
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	35.5
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	35.3
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	35.0
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	34.8
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	34.7
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	34.6
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	34.5
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	34.5
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	34.3
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	34.3
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	33.9
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	33.9
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	33.6
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	33.6
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	33.2
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	33.2
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	33.1
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	33.1
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	33.0
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	32.9
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	32.8
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	32.7
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	32.6
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	32.6
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	32.6
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	32.5
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	32.5
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	32.4
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	32.3
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	31.8
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	31.7
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	31.6
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	31.3
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	31.1
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	31.0
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	30.9
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	30.7
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	30.7
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	30.6
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	30.6
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	30.0
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	29.6
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	29.6
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	29.5
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	29.4
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	29.3
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	29.1
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	28.9
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	28.7
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	28.3
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	28.2
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	28.1
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	28.1
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	27.7
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	27.6
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	27.5
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	27.2
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	27.2
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	26.9
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	26.6
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	26.5
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	26.4
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	26.2
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	26.2
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	25.7
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	25.6
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	25.4
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	25.4
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	25.1
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	25.0
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	25.0
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	24.8
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	24.4
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	24.2
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	24.2
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	24.1
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	24.1
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	24.0
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	23.4
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	23.4
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	23.1
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	22.1
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	19.8
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	19.0
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	17.9
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	17.7
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	17.5
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	17.5
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	16.2
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	15.7
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	13.2
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

PRPSAP1 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 5.6

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

5.0

Number of samples

Samples

Sample	Description	TPM
AK002	N, NA, stage:NA, dead, 570 days	8.9
AK041	N, NA, stage:NA, alive, 810 days	7.0
AK076	N, NA, stage:NA, alive, 660 days	6.8
AK133	N, NA, stage:NA, dead, 360 days	6.8
AK079	N, NA, stage:NA, dead, 210 days	6.6
AK003	N, NA, stage:NA, dead, 600 days	6.5
AK205	N, NA, stage:NA, dead, 120 days	6.5
AK085	N, NA, stage:NA, alive, 660 days	6.5
AK102	N, NA, stage:NA, alive, 1740 days	6.4
AK068	N, NA, stage:NA, alive, 360 days	6.4
AK089	N, NA, stage:NA, dead, 330 days	6.2
AK149	N, NA, stage:NA, dead, 420 days	6.1
AK103	N, NA, stage:NA, alive, 1320 days	5.6
AK081	N, NA, stage:NA, dead, 180 days	5.6
AK213	N, NA, stage:NA, alive, 2010 days	5.6
AK226	N, NA, stage:NA, dead, 360 days	5.6
AK035	N, NA, stage:NA, dead, 210 days	5.6
AK173	N, NA, stage:NA, dead, 180 days	5.6
AK156	N, NA, stage:NA, dead, 330 days	5.5
AK015	N, NA, stage:NA, alive, 720 days	5.4
AK049	N, NA, stage:NA, dead, 180 days	5.4
AK216	N, NA, stage:NA, dead, 360 days	5.4
AK185	N, NA, stage:NA, alive, 330 days	5.3
AK167	N, NA, stage:NA, dead, 180 days	5.2
AK099	N, NA, stage:NA, dead, 420 days	5.1
AK006	N, NA, stage:NA, dead, 360 days	5.0
AK218	N, NA, stage:NA, dead, 180 days	5.0
AK043	N, NA, stage:NA, alive, 660 days	4.9
AK051	N, NA, stage:NA, dead, 360 days	4.9
AK124	N, NA, stage:NA, alive, 1920 days	4.9
AK123	N, NA, stage:NA, dead, 180 days	4.9
AK117	N, NA, stage:NA, dead, 210 days	4.9
AK066	N, NA, stage:NA, alive, 960 days	4.7
AK088	N, NA, stage:NA, dead, 360 days	4.7
AK142	N, NA, stage:NA, alive, 90 days	4.7
AK030	N, NA, stage:NA, dead, 120 days	4.6
AK158	N, NA, stage:NA, dead, 360 days	4.6
AK071	N, NA, stage:NA, dead, 540 days	4.6
AK134	N, NA, stage:NA, dead, 360 days	4.6
AK098	N, NA, stage:NA, dead, 660 days	4.6
AK100	N, NA, stage:NA, alive, 960 days	4.5
AK199	N, NA, stage:NA, alive, 1860 days	4.5
AK231	N, NA, stage:NA, dead, 240 days	4.5
AK053	N, NA, stage:NA, dead, 300 days	4.4
AK139	N, NA, stage:NA, dead, 270 days	4.2
AK072	N, NA, stage:NA, dead, 150 days	4.2
AK074	N, NA, stage:NA, alive, 300 days	4.1
AK236	N, NA, stage:NA, dead, 360 days	4.1
AK091	N, NA, stage:NA, dead, 210 days	4.0
AK178	N, NA, stage:NA, dead, 240 days	4.0
AK153	N, NA, stage:NA, dead, 240 days	3.9
AK227	N, NA, stage:NA, alive, 300 days	3.9
AK195	N, NA, stage:NA, dead, 390 days	3.8
AK005	N, NA, stage:NA, dead, 240 days	3.8
AK183	N, NA, stage:NA, alive, 360 days	3.7
AK055	N, NA, stage:NA, dead, 240 days	3.7
AK188	N, NA, stage:NA, alive, 420 days	3.7
AK165	N, NA, stage:NA, alive, 360 days	3.4
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0221180003	Tumor	0.7
CPT0093590003	Tumor	0.6
CPT0092440003	Tumor	0.6
CPT0218670003	Tumor	0.6
CPT0218770003	Tumor	0.6
CPT0002410011	Tumor	0.5
CPT0204340003	Normal	0.5
CPT0204330003	Normal	0.5
CPT0204400003	Normal	0.5
CPT0204420003	Normal	0.5
CPT0204370003	Normal	0.5
CPT0204390003	Normal	0.5
CPT0190240004	Tumor	0.4
CPT0204410003	Normal	0.4
CPT0205570003	Tumor	0.4
CPT0189750004	Tumor	0.4
CPT0218830004	Tumor	0.4
CPT0217880003	Tumor	0.4
CPT0162100003	Tumor	0.4
CPT0087730003	Tumor	0.4
CPT0093510003	Tumor	0.4
CPT0217190003	Tumor	0.4
CPT0104220003	Tumor	0.4
CPT0204350003	Normal	0.3
CPT0204380003	Normal	0.3
CPT0206000004	Tumor	0.3
CPT0071100003	Tumor	0.3
CPT0224330003	Tumor	0.3
CPT0204360003	Normal	0.3
CPT0217000004	Tumor	0.3
CPT0125570003	Tumor	0.2
CPT0168380003	Tumor	0.2
CPT0207030003	Tumor	0.2
CPT0206670004	Tumor	0.2
CPT0127480003	Tumor	0.2
CPT0225730003	Tumor	0.2
CPT0186100003	Tumor	0.2
CPT0168830003	Tumor	0.2
CPT0206780003	Tumor	0.2
CPT0206110003	Tumor	0.2
CPT0224600003	Tumor	0.2
CPT0167750004	Tumor	0.2
CPT0206330003	Tumor	0.2
CPT0182580003	Tumor	0.2
CPT0217430008	Tumor	0.2
CPT0064650003	Tumor	0.2
CPT0168590003	Tumor	0.2
CPT0206560003	Tumor	0.1
CPT0189460003	Tumor	0.1
CPT0168480003	Tumor	0.1
CPT0224540004	Tumor	0.1
CPT0199770003	Tumor	0.1
CPT0125220003	Tumor	0.1
CPT0196850003	Tumor	0.1
CPT0206450003	Tumor	0.1
CPT0189250003	Tumor	0.1
CPT0189650004	Tumor	0.1
CPT0127420003	Tumor	0.1
CPT0175060003	Tumor	0.1
CPT0168720003	Tumor	0.1
CPT0228220003	Tumor	0.1
CPT0162140003	Tumor	0.1
CPT0125510003	Tumor	0.1
CPT0087570003	Tumor	0.1
CPT0093550003	Tumor	0.0
CPT0167640003	Tumor	0.0
CPT0217710008	Tumor	0.0
CPT0209440003	Tumor	0.0
CPT0216920008	Tumor	0.0
CPT0189850004	Tumor	0.0
CPT0218890004	Tumor	0.0
CPT0205780003	Tumor	0.0
CPT0182500003	Tumor	0.0
CPT0208980003	Tumor	0.0
CPT0162020003	Tumor	0.0
CPT0206880003	Tumor	0.0
CPT0217060003	Tumor	0.0
CPT0161730003	Tumor	0.0
CPT0064890003	Tumor	-0.1
CPT0190360004	Tumor	-0.1
CPT0079790003	Tumor	-0.1
CPT0205890003	Tumor	-0.1
CPT0167860004	Tumor	-0.1
CPT0167530003	Tumor	-0.1
CPT0182550003	Tumor	-0.1
CPT0167970003	Tumor	-0.1
CPT0205450004	Tumor	-0.1
CPT0104330003	Tumor	-0.1
CPT0225760003	Tumor	-0.1
CPT0168270003	Tumor	-0.1
CPT0123530003	Tumor	-0.1
CPT0218960004	Tumor	-0.1
CPT0201710003	Tumor	-0.1
CPT0219080004	Tumor	-0.2
CPT0087680003	Tumor	-0.2
CPT0089150003	Tumor	-0.2
CPT0207090003	Tumor	-0.2
CPT0205670004	Tumor	-0.2
CPT0217100003	Tumor	-0.2
CPT0224390004	Tumor	-0.2
CPT0093360003	Tumor	-0.2
CPT0171580008	Tumor	-0.2
CPT0087950003	Tumor	-0.3
CPT0168080003	Tumor	-0.3
CPT0206230003	Tumor	-0.3
CPT0218330004	Tumor	-0.3
CPT0189570004	Tumor	-0.4
CPT0078580003	Tumor	-0.4
CPT0218690004	Tumor	-0.4
CPT0093450003	Tumor	-0.5
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis